RNase P ribozymes for the studies and treatment of human cytomegalovirus infections

Journal of Clinical Virology

Volumn 25, Issue SUPPL. 2, 2002, Pages 63-74

  Trang, Phong ^a   Kilani, Ahmed ^a   Lee, Jarone ^a   Hsu, Amy ^a   Liou, Kwa ^a   Kim, Joe ^a   Nassi, Arash ^a   Kim, Kihoon ^a   Liu, Fenyong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytomegalovirus; Gene targeting; Herpesvirus; Ribozyme; RNase P

Indexed keywords

MESSENGER RNA; RIBONUCLEASE P; RIBOZYME; THYMIDINE KINASE; VIRUS RNA;

ARTICLE; CATALYSIS; CELL CULTURE; CYTOMEGALOVIRUS INFECTION; ENZYME ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENETIC CODE; GENETIC SELECTION; GROWTH INHIBITION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; KINETICS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RNA CLEAVAGE; RNA SEQUENCE; RNA STRUCTURE; VIROGENESIS; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0036702342     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6532(02)00097-5     Document Type: Article

References (55)

1. Altman S., Kirsebom L.A. Ribonuclease P. Gesteland R.F., Cech T.R., Atkins J.F., The RNA World. 1999;351-380 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
2. Anderson K.P., Fox M.C., Brown-Driver V., Martin M.J., Azad R.F. Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA. Antimicrob. Agents Chemother. 40:1996;2004-2011.
3. Ares M., Igel A.H. Lethal and temperature-sensitive mutations and their suppressors identify an essential structural element in U2 small nuclear RNA. Genes Dev. 4:1990;2132-2145.
4. Azad R.F., Driver V.B., Tanaka K., Crooke R.M., Anderson K.P. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob. Agents Chemother. 37:1993;1945-1954.
5. Azad R.F., Brown-Driver V., Buckheit R.W., Anderson K.P. Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs. Antiviral Res. 28:1995;101-111.
6. Bertrand E.L., Rossi J.J. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J. 13:1995;2904-2912.
7. Bertrand E., Castanotto D., Zhou C., Carbonnelle C., Lee N.S., Good P., Chatterjee S., Grange T., Pictet R., Kohn D., Engelke D., Rossi J.J. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA. 3:1997;75-88.
8. Britt W.J., Alford C.A. Cytomegalovirus. Fields B.N., Knipe D.M., et al. Virology. third ed. 1996;2493-2523 Raven Press, New York.
9. Bryant L.A., Sinclair J.H. Inhibition of human cytornegalovirus major immediate early gene expression by antisense RNA expression vectors. J. Gen. Virol. 74:1993;1965-1967.
10. Cantin E.M., Podsakoff G., Willey D.E., Openshaw H. Antiviral effects of herpes simplex virus specific anti-sense nucleic acids. Adv. Exp. Med. Biol. 312:1992;139-149.
11. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
12. Chen D.H., Hong J., Lee M., Liu F., Zhou Z.H. Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology. 260:1999;10-16.
13. Dal Monte P., Bessia C., Ripalti A., Landini M.P., Topilko A., Plachter B., Virelizier J.L., Michelson S. Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication. J. Virol. 70:1996;2086-2094.
14. Das G., Henning D., Wright D., Reddy R. Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III. EMBO J. 7:1988;503-512.
15. Forster A.C., Altman S. External guide sequences for an RNA enzyme. Science. 249:1990;783-786.
16. Frank D.N., Pace N.R. Ribonuclease P: unity and diversity in a tRNA processing ribozyme. Ann. Rev. Biochem. 67:1998;153-180.
17. Frank D., Harris M., Pace N.R. Rational design of self-cleaving pre-tRNA-Ribonuclease P RNA conjugates. Biochemistry. 33:1994;10800-10808.
18. Gardiner K.J., Marsh T.L., Pace N.R. Ion dependence of the Bacillus subtilis RNase P reaction. J. Biol Chem. 260:1985;5415-5419.
19. Gold L., Alien P., Binkley J., Brown D., Schneider D., Eddy S.R., Tuerk C., Green L., MacDougal S., Tasset D. RNA: the shape of things to come. Gesteland R.R., Atkins J.F., The RNA World. 1993;497-509 Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
20. Good P.O., Krikos A.J., Li S.X., Bertrand E., Lee N.S., Giver L., Ellington A., Zaia J.A., Rossi J.J., Engelke D.R. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther. 4:1997;45-54.
21. Greaves R.F., Mocarski E.S. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72:1998;366-379.
22. Guerrier-Takada C., Gardiner K., Marsh T., Pace N., Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell. 35:1983;849-857.
23. Haas E.S., Brown J.W., Pitulle C., Pace N.R. Further perspective on the catalytic core and secondary structure of ribonuclease P RNA. Proc. Natl. Acad. Sci. USA. 91:1994;2527-2531.
24. Herschlag D., Khosla M., Tsuchihashi Z., Karpel R.L. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 13:1995;2913-2924.
25. Hsu A.W., Kilani A.F., Liou K., Lee J., Liu F. Differential effects of the protein cofactor on the interactions between a RNase P ribozyme and its target mRNA substrate. Nucleic Acids Res. 28:2000;3105-3116.
26. Joyce G.F. Directed molecular evolution. Sci. Am. 267:1992;90-97.
27. Kilani A.F., Liu F. UV crosslink mapping of the substrate binding site of RNase P ribozyme to a target mRNA sequence. RNA. 5:1999;1235-1247.
28. Kilani A.F., Trang P., Jo S., Hsu A., Kim J., Nepomuceno E., Liou K., Liu F. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J. Biol. Chem. 275:2000;10611-10622.
29. Liu F., Altman S. Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli. Genes Dev. 9:1995;471-480.
30. Liu F., Altman S. Requirements for cleavage by a modified RNase P of a small model substrate. Nucleic Acids Res. 24:1996;2690-2696.
31. Marchini A., Liu H., Zhu H. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:2001;1870-1878.
32. Massire C., Jaeger L., Westhof E. Derivation of the three-dimensional architecture of bacterial ribonuclease P RNAs from comparative sequence analysis. J. Mol. Biol. 279:1998;773-793.
33. McClain W.H., Guerrier-Takada C., Airman S. Model substrates for an RNA enzyme. Science. 238:1987;527-530.
34. Mocarski E.S., Courcelle C.T. Cytomegaloviruses and their replication. Knipe D.M., Howley P.M., Fields Virology. 2:2001;2629-2674 Lippincott Williams & Wilkins, Philadelphia.
35. Mocarski E.S., Kemble G.W., Lyle J.M., Greaves R.F. A deletion mutant in the human cytomegalovirus gene encoding IEl(491aa) is replication defective due to a failure in autoregulation. Proc. Natl. Acad. Sci. USA. 93:1996;11321-11326.
36. Mulamba G.B., Hu A., Azad R.K., Anderson K.P., Coen D.M. Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922). Antimicrob. Agents Chemother. 42:1998;971-973.
37. Pari G.S., Field A.K., Smith J.A. Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of humancytomegalovirus genes UL36 and UL37. Antimicrob. Agents Chemother. 39:1995;1157-1161.
38. Poeschla E., Wong-Staal F. Antiviral and anticancer ribozymes. Curr. Opin. Oncol. 6:1994;601-606.
39. Ripalti A., Boccuni M.C., Campanini F., Landini M.P. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J. Virol. 69:1995;2047-2057.
40. Roizman B., Knipe D.M. Herpes simplex viruses and their replication. Knipe D.M., Howley P.M., Fields Virology. 2:2001;2399-2640 Lippincott Williams & Wilkins, Philadelphia.
41. Rossi J.J. Ribozymes, genomics and therapeutics. Chem. Biol. 6:1999;R33-R37.
42. Sarver N., Cantin E.M., Chang P.S., Zaia J.A., Ladne P.A., Stephens D.A., Rossi J.J. Ribozymes as potential anti-HIV-1 therapeutic agents. Science. 247:1990;1222-1225.
43. Smith J.A., Pari G.S. Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication. J. Virol. 69:1995;1925-1931.
44. Stein C.A., Cheng Y.C. Antisense oligonucleotides as therapeutic agents - is the bullet really magical. Science. 261:1993;1004-1012.
45. Stenberg R.M., Depto A.S., Fortney J., Nelson J.A. Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J. Virol. 63:1989;2699-2708.
46. Szostak J.W. In vitro genetics. Trends Biochem. Sci. 17:1992;89-93.
47. Trang P., Hsu A.W., Liu F. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate. Nucleic Acids Res. 27:1999;4590-4597.
48. Trang P., Kilani A.F., Kim J., Liu F. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. J. Mol. Biol. 301:2000a;817-826.
49. Trang P., Lee M., Nepomuceno E., Kim J., Zhu H., Liu F. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proc. Natl. Acad. Sci. USA. 97:2000b;5812-5817.
50. Tsuchihashi Z., Khosla M., Herschlag D. Protein enhancement of hammerhead ribozyme catalysis. Science. 262:1993;99-102.
51. Whitely R.J. Herpes simplex viruses. Fields B.N., Knipe D.M., et al. Virology. third ed. 1996;2297-2342 Raven Press, New York.
52. Yu M., Ojwang J., Yamada O., Hampel A., Rapapport J., Looney D., Wong-Staal F. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 90:1993;6340-6344.
53. Yuan Y., Hwang E., Airman S. Targeted cleavage of mRNA by human RNase P. Proc. Natl. Acad. Sci. USA. 89:1992;8006-8010.
54. Zamecnik P.C., Stephenson M.L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA. 75:1978;280-284.
55. Zaug A.J., Cech T.R. Analysis of the structure of Tetrahymena nuclear RNAs in vivo: telomerase RNA, the self-splicing rRNA intron, and U2 snRNA. RNA. 1:1995;363-374.